MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
ARCH Venture Partners - (#8 Healthcare Investor 2013) WBT
Finance & Acquisitions: Arch Ventures
Parents
ARCH Venture Partners - (#8 Healthcare Investor 2013) WBT
Children
*Portfolio Companies: Arch Ventures
2011: bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners (2011)
Acylin has secured an undisclosed Series A venture round (typically $4 million) from Alexandria Real Estate Equities, Amgen Ventures, Arch Venture Partners, OVP Ventures
Agios previously raised $33 million in a Series A round of funding from Boston-area firms Third Rock Ventures and Flagship Ventures, as well as Arch Venture Partners
Also participating were Menlo Park-based Sofinnova Ventures inc., Chicago-based ARCH Venture PartnersbizWatch ARCH Venture Partners Latest from The Business Journals Sorbent raises M for heart failure drugBay Area transplant Sorbent Therapeutics raises MBa
Amount: $3.585M Round: Venture Capital Past Investor(s) OVP Venture Partners, Arch Venture Partners, Sevin Rosen Funds, Altitude Funds
Amount: $31M Round: Series E Investor(s) Saints Capital, BSI SA, Newbury Acquisitions Fund, Pitango Venture Capital, Giza Venture Capital, ONSET Ventures, Three Arch Partners, Generali Financial Holding
Amt: 6M Round: Series B Investor(s) Versant Ventures, Alexandria Real Estate Equities, Arch Venture Partners, OVP Venture Partners, WRF Capital (2011)
Investors: Frazier Healthcare Ventures, Alta Partners, 5 AM Ventures, ARCH Venture Partners, Domain Associates, Venrock Associates, Versant Ventures and the Wellcome Trust
Participants include Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, PPD and Washington Research Foundation Capital.
Polaris, ARCH Venture Partners put $15M behind launch of deCODE genetics spinoff NextCODE-medcitynews (2013)
Secured $30.2 million in Series B financing, ARCH Venture Partners and Novartis Bioventures Fund co-led the round with participation from existing investors Polaris Venture Partners and 5AM Ventures.
Series A, iinvestment from Alexandria Real Estate Equities, Amgen Ventures, ARCH Venture Partners, OVP Venture Partners, and WRF
Series B led by OVP Venture Partners,and Astellas Venture Management, Genzyme Ventures, ARCH Venture Partners, Polaris Venture Partners and Venrock
The financing includes a new investor, ARCH Venture Partners, in addition to support from existing investors Third Rock Ventures, TVM Capital, Forbion Capital Partners and Easton Capital Investment Group
The new company also said it’s secured $15 million in Series A financing from Polaris Partners and ARCH Venture Partners, the same pair of investors that bought deCODE out of bankruptcy in 2010.
The Series B round was led by AllianceBernstein L.P., and Series A investors Arch Venture Partners, NGEN Partners, Vanguard Ventures.
VENTURE FUNDING TOTAL $55M - Texas Pacific Group, MPM Capital, ARCH Venture Partners, OVP Venture Partners, Amgen Ventures, MedImmune Ventures, WRF Capital (2006)
Venture investors include ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.
Jumps
*Key People: Arch Ventures
Organization & Developments: Arch Ventures